Platelet reactivity increased in HIV patients with ACS on dual antiplatelet therapy

21-1-2017 • Hauguel-Moreau M et al., Eur Heart Jl 2017
In HIV-ACS patients of the EVERE2ST-HIV study, platelet reactivity and residual platelet reactivity were increased with P2Y12 receptor inhibitors and aspirin, compared to non-HIV ACS patients. Read more
News • 18-1-2017

Substantial increase in high SBP and associated morbidity between 1990 and 2015

A global analysis including over 8 million people revealed an increasing rate of SBP above 110 mmHg between 1990 and 2015, which accounts for an estimated 17.8 million deaths in 2015. Read more

Lower risk of liver injury hospitalisation with DOACs as compared to warfarin

10-1-2017 • Alonso A et al., Heart. 2017
Dabigatran, rivaroxaban and apixaban users were less often associated with liver injury hospitalisation compared to warfarin and several variables could predict this. Read more

Frequency of off-label dosing of NOACs and its consequences

22-12-2016 • Steinberg BA et al., JACC 2016
Many AF patients on NOAC therapy do not receive recommended doses for stroke prevention, and are at increased risk for CV hospitalisation and all-cause mortality. Read more

CVD risk-associated inflammatory markers increased with smoking heaviness

14-12-2016 • King CC, Arterioscler Thromb Vasc Biol, 2017

Inflammatory markers urinary F2:Cr ratio, myeloperoxidase and WBC counts correlated with smoking heaviness. F2:Cr ratio and WBC reduced after cessation. 

Read more

Young current smokers highest chance of experiencing an acute STEMI

7-12-2016 • Lloyd A, Heart, 2016
Compared to ex- or never-smokers, current smokers had a 3 times higher chance of acute STEMI, and this chance was even higher among the younger. Read more

Inadequate treatment in many post-ACS patients

19-1-2017 • Eisen A et al., J Am Heart Assoc. 2017
In a large, multinational, post-ACS population, most patients were not treated with high-potency statin regimens early and late after the event which is contradictory to protocols. Read more

Weekend sports may suffice to reduce mortality risk

12-1-2017 • O’Donovan G et al., JAMA Intern Med 2017
In a large analysis of 11 population-based cohorts, different physical activity patterns were associated with reduced risks for all-cause-, CVD-, and cancer mortality. Read more

HFpEF patients with diabetes are worse off than are those without diabetes

10-1-2017 • Kristensen SL et al., Circulation 2017
HFpEF patients with diabetes have worse quality of life, higher NT-proBNP levels, more echocardiographic abnormalities and worse outcomes compared with those without diabetes. Read more

Higher risk of developing atrial fibrillation with moderate alcohol consumption

19-12-2016 • Voskoboinik A et al., JACC 2016
The cardioprotective effects attributed to alcohol do not apply to AF, as regular moderate consumption (~7-21 drinks/week), predisposes to AF, with an increase in AF recurrence in those who continue to drink. Read more

Risk of CAD in individuals with genetic risk can be reduced with healthy lifestyle

8-12-2016 • Khera AV, et al, NEJM, 2016
A healthy lifestyle contributed to a substantial risk reduction of CAD in people with low, intermediate or high genetic risk for CAD. Read more

All-cause and CVD mortality reduced with certain sports

7-12-2016 • Oja P, et al, Br J Sports Med, 2016
Motivate individuals to participate certain sports, as swimming, racquet sports and aerobics reduced all-cause and CVD mortality and also cycling reduced all-cause mortality.  Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...